New Phase II study shows first-line promise of lung cancer drug PF-299
Wednesday, October 13, 2010 - 10:02
in Health & Medicine
A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO)...